InsidersTradesSigma
Wuhan YZY Biopharma Co., Ltd. - B: insider trades · Hong Kong · HKEX
HKEX:wuhan-yzy-biopharma-co-ltd-b-h-sharesHK·HKEXMcap 1.0Bn€Healthcare
Discover the full management transaction log of Wuhan YZY Biopharma Co., Ltd. - B, a publicly traded company based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, Wuhan YZY Biopharma Co., Ltd. - B has logged 8 reports. Market capitalisation: €1bn. The latest transaction was disclosed on 1 April 2026 (Purchase). Among the most active insiders: WEN Zhicheng. All data is accessible without an account.
8
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
4 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
5.16 €
Analyst consensus
Income statement
Revenue66.9 M€
Gross profit10.7 M€16% margin
Net income−84.7 M€-126.7% margin
Valuation
Beta0.49
Balance sheet & cash
Market cap1.04 Bn€
Total debt127.8 M€
Free Cash Flow−22.5 M€
Profitability & ownership
ROA-22.7%
% insiders73.4%
% institutions21.6%
Last declaration on 1 April 2026
Declarations0 total
No declarations found
0 of 0 declarations